coteauBeta Get App
OSCR

OSCR

OSCR
$33.45
-0.62% Oct 21 close
Sector n/a Compare
-46%-17%+12%+41%+70%Oct 2025Oct 2026Apr 2026
OSCRSPY
1W
-2.5%
1M
+6.9%
3M
+13.4%
6M
+103.5%
YTD
+132.8%
1Y
+53.7%

Live chart

Loading live chart…

What they do

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products.

Healthcare · Healthcare Plans

For information only · Important disclosures

Grades vs sector

No sector grades for OSCR yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Our models

Not held by any of our 5 live models right now.

Quality Growth
Outside this model's universe or screens
Momentum Top 15
Outside this model's universe or screens
Momentum Blend
Not in the current book
New Highs Growth
Outside this model's universe or screens
Coteau Long Book
Not in the current book

News

More news
Oscar Health vs. Molina: Which Healthcare Stock Is a Better Buy?
Zacks · Oct 16
3 US Managed Care Stocks Facing Election And Healthcare Cost Pressure
Simply Wall St. · Oct 15

Key stats

52-week range$10.85 – $34.32
Valuation and fundamentals

Valuation & fundamentals

Bottom line
No cash-flow valuation
Model read-out from the numbers below, not advice. Score +0 (DCF counts double).
•Piotroski F-score4/9
▲Net debt / EBITDA-12.3x

Discounted cash flow

Trailing free cash flow is negative or missing, so a cash-flow DCF isn't meaningful by default. You can enter your own assumptions below.
Reverse DCFfor context, not a signal
Not enough data to run a reverse DCF.
Edit assumptions · recalculates instantly
Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.00 (n/a) × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs sector

Quality & financial health

Gross margin
–
Operating margin
4.1%
FCF margin
28.8%
Net margin
3.6%
Return on equity
26.8%
Return on invested capital
–
Net debt / EBITDA
-12.3×
Current ratio
1.1×
Interest cover
39.7×
Cash conversion (OCF/NI)
8.0×
Piotroski F-score 4/9 · last two fiscal years
✗ Positive net income✓ Positive operating cash flow✗ Return on assets improved✓ Cash flow above net income✗ Long-term debt / assets fell✓ Current ratio improved✓ No share dilution✗ Gross margin improved✗ Asset turnover improved

Analysts

No analyst targets available.

Annual history

FYRevenueNet incomeFree cash flow
2025$11.7B$-443.2M$1.1B
2024$9.2B$25.4M$978.2M
2023$5.9B$-270.7M$-272.2M
2022$4.0B$-606.3M$380.3M
2021$1.8B$-572.6M$-181.7M
2020$462.8M$-406.8M$222.7M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +43.5%.

Earnings

Next report: 2026-11-05 · before open · EPS est -0.17
24-1125-0225-0525-0825-1126-0226-0526-08-1.242.07
EstimateActual (beat)Actual (miss)
ReportEPS estActualSurprise
2026-08-060.381.10+189.2%
2026-05-061.102.07+88.2%
2026-02-10-0.92-1.24-34.6%
2025-11-06-0.58-0.53+8.7%
2025-08-06-0.84-0.89-6.5%
2025-05-070.810.92+13.9%
2025-02-04-0.58-0.62-6.5%
2024-11-07-0.18-0.22-25.0%
Insider trades
Wittman Vanessa Ames
Director · 2026-09-18
Sell
$806.0K
Schlosser Mario
Director · 2026-09-03
Sell
$988.2K
Mcananey Adam
Chief Legal Officer · 2026-09-03
Sell
$285.9K
Blackley Richard Scott
Chief Financial Officer · 2026-09-03
Sell
$907.9K
Baltrus Victoria
Chief Accounting Officer · 2026-09-03
Sell
$30.1K
Liang Janet
President, Oscar Insurance · 2026-09-03
Sell
$325.8K
Schlosser Mario
Director · 2026-08-28
Sell
$4.6M
Schlosser Mario
Director · 2026-08-27
Sell
$18.2M
Blackley Richard Scott
Chief Financial Officer · 2026-08-18
Sell
$595.1K
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-21 18:27:22 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Free. Not investment advice. Unsubscribe anytime.

coteau

Independent research · Not investment advice · Important disclosures · Contact desk@coteau.app

Coteau Systematic Strategies publishes stock research and model portfolios. Results are hypothetical unless marked Live. Data: Yahoo Finance (15-min delayed), SEC EDGAR and the House Clerk.

Beta 0.9 · Oct 21, 2026